PRSS50 and breast carcinoma: Therefore, we investigated the effects of different TSP50 mutants on p110α activity and found that p110α activity was significantly decreased only in TSP50 D206A mutated breast cancer cells compared with the TSP50 wild-type group (Fig. 8A and B).